[1]易洪彬,刘 爽,徐冬艳,等.处方流转的驱动与阻碍因素研究 ——基于医疗机构视角[J].卫生经济研究,2024,41(11):71-73.
　YI Hongbin,LIU Shuang,XU Dongyan,et al.Study on the Driving and Hindering Factors of Prescription Circulation ——From the Persperctive of Medical Institutions[J].Journal Press of Health Economics Research,2024,41(11):71-73.
点击复制

处方流转的驱动与阻碍因素研究
——基于医疗机构视角
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年11期
页码:
71-73
栏目:
药械管理
出版日期:
2024-10-31

文章信息/Info

Title:
Study on the Driving and Hindering Factors of Prescription Circulation
——From the Persperctive of Medical Institutions
作者:
易洪彬1; 2; 刘 爽3; 徐冬艳4; 蒯丽萍4; 韩 晟1; 2
1.北京大学医药管理国际研究中心，北京 100191
2.北京大学药学院，北京 100191
3.河北北方学院药学院，河北 张家口 075031
4.中国药学会科技开发中心，北京 100022
Author(s):
YI Hongbin;  LIU Shuang;  XU Dongyan;  KUAI Liping;  HAN Sheng
International Research Center for Medicinal Administration, Peking University, Beijing 100191, China
关键词:
处方流转; 医疗机构; 半结构化访谈
Keywords:
prescription circulation;  medical institutions;  semi-structured interview
分类号:
R95
文献标志码:
A
摘要:
目的：了解处方流转的现状和问题，提出相应的对策。方法：对5个省区市15家医疗机构的相关人员进行半结构化访谈。结果：9家医疗机构处方流转比例小于5%；处方流转的驱动因素有提高患者便利性、节约时间成本、保障患者自主选择权、防止交叉感染、提高药品可及性、降低医院管理成本，处方流转的阻碍因素是利益补偿机制缺乏、医保对接不完善、患者信任度较低、社会药店药事服务能力较弱、数据安全风险和数据互通障碍。结论：医疗机构处方流转效果不佳，应建立合理的利益分配机制，加大政策扶持力度，提升社会药店药事服务能力，加强患者引导和舆论宣传，引入第三方流转平台，结合地域特点设计相关机制与政策，促进处方流转。
Abstract:
Objective To understand the current situation and problems of prescription circulation, and to put forward corresponding countermeasures. Methods The relevant personnel of 15 medical institutions in five provincial-level administrative regions were semi-structured interviewed. Results 9 surveyed medical institutions had a turnover ratio of less than 5%. The driving factors of prescription circulation were improving patient convenience, saving time and cost, ensuring patient independent choice, preventing cross-infection, improving drug accessibility and reducing hospital management cost. The hindering factors of prescription circulation were the lack of interest compensation mechanism, inadequate integration with medical insurance, low patient trust, weak service capacity of social pharmacies, data security risks and data interoperability obstacles. Conclusion Most of the investigated medical institutions have poor prescription transfer effect. It is necessary to establish a reasonable benefit distribution mechanism, increase the policy support for the linkage and coordination of health care, improve the service capacity of social pharmacies, do a good job in patient guidance and public opinion publicity, introduce a third-party circulation platform, and design relevant mechanisms and policies based on regional characteristics to promote prescription circulation.

参考文献/References:

[1] 陆鹏宇，田侃，朱祥源.医院处方流转实践模式研究[J].卫生经济研究，2021，38（01）：58-61.
[2] 高弘杨.处方外流的堵与疏[J].中国药店，2024（02）：37-39.
[3] 吴培，董晨东，茅宁莹.“互联网+”背景下处方外流推进障碍与对策分析——基于利益相关者视角[J].中国药房，2021，32（12）：1409-1415.
[4] 金圣玹，葛雪雯，毛如虎，等.处方外流发展现状及问题探析[J].中国卫生质量管理，2020，27（03）：125-127.

相似文献/References:

[1]许 涛,萧 潇,赵丽颖,等.台湾地区医院财经政策与监管[J].卫生经济研究,2016,(11):26.
[2]谭华伟,张培林,张 云,等.我国医疗机构债务规模扩张与医疗费用增长的互动效应研究[J].卫生经济研究,2017,(02):35.
[3]陈 伟,蒋 丹.医保支付方式变革对医疗机构发展战略的影响分析[J].卫生经济研究,2017,(05):60.
[4]吴显兰,袁永强.医疗机构检查检验结果互认之思考[J].卫生经济研究,2017,(06):53.
[5]齐兰兰.广州市医疗设施利用的时空间特征研究[J].卫生经济研究,2018,(04):56.
[6]武 宁,李姝晴,党 媛.全国医疗机构护士需求测算研究[J].卫生经济研究,2019,(07):33.
　WU Ning,LI Shu-qing,DANG Yuan.Research on the Measurement of Nurses' Needs in National Medical Institutions[J].Journal Press of Health Economics Research,2019,(11):33.
[7]舒 茜,姚峥嵘,王艳翚,等.药品带量采购政策的利益相关者分析[J].卫生经济研究,2019,(08):8.
　SHU Qian,YAO Zheng-rong,WANG Yan-hui,et al.Stakeholder Analysis of Drug Consumption Policy[J].Journal Press of Health Economics Research,2019,(11):8.
[8]顾 海,吴 迪,景抗震.以医疗机构为主导的远程诊断与护理体系研究 ——基于复杂适应系统理论[J].卫生经济研究,2019,(10):52.
　GU Hai,WU Di,JING Kang-zhen.Research on Remote Diagnosis and Nursing System Led by Medical Institutions——Based on the Theory of Complex Adaptive Systems[J].Journal Press of Health Economics Research,2019,(11):52.
[9]谭 松,伍林生,罗添文,等.重庆市医疗责任保险运行的实证研究及对策分析[J].卫生经济研究,2020,(06):16.
　TAN Song,WU Lin-sheng,LUO Tian-wen,et al.An Empirical Study and Countermeasures Analysis on the Operation of Chongqing Medical Liability Insurance[J].Journal Press of Health Economics Research,2020,(11):16.
[10]杜 雪,马 珺,黎雯霞.药品带量采购存在的问题与对策分析[J].卫生经济研究,2020,(08):42.
　DU Xue,MA Jun,LI Wen-xia.Problems and Countermeasures on Existing in the Development of Drug Volume Procurement[J].Journal Press of Health Economics Research,2020,(11):42.

更新日期/Last Update: 2024-10-31